SCHEMBL3305710

SCHEMBL3305710

C=CCN(CC=C)C([C]=O)C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565988 0.68
SCHEMBL460593 0.67 ALDH1A1 (0.31)
SCHEMBL4943866 0.67
SCHEMBL1558572 0.67
SCHEMBL8521033 0.67
SCHEMBL87508 0.67
SCHEMBL2578714 0.64 ALDH1A1 (0.31)
SCHEMBL9816555 0.62
SCHEMBL526564 0.62 ALDH1A1 (0.31)
SCHEMBL6057564 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420630-B2 Pyrimidine derivatives BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2013-04-16 US claimed
EP-2090571-B1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation BOEHRINGER INGELHEIM PHARMA (DE) 2012-05-16 EP claimed
US-20100152167-A1 PYRIMIDINE DERIVATIVES BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-06-17 US claimed
JP-4460292-B2 2010-05-12 JP claimed
US-7709480-B2 Pyrimidine derivatives BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-05-04 US claimed
EP-1438053-B1 PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME BOEHRINGER INGELHEIM PHARMA (DE) 2008-09-10 EP claimed
US-7173028-B2 Pyrimidine derivatives BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-02-06 US claimed
US-20060100211-A1 Pyrimidine derivatives BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-05-11 US claimed
JP-2005509624-A 2005-04-14 JP claimed
EP-1438053-A1 PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-07-21 EP claimed
US-20030171359-A1 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-09-11 US claimed
WO-2003032997-A1 PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-04-24 WO claimed
EP-0941215-A1 GLYOXYLIC ACID AMIDES AND THEIR USE AS PESTICIDES BAYER AG (DE) 1999-09-15 EP claimed
EP-0865240-A1 USE OF 1,2,3-THIADIAZOLE CARBOXYLIC ACID (THIO)ESTERS FOR THE CONTROL OF PESTS AND NOVEL 1,2,3-THIADIAZOLE CARBOXYLIC ACID (THIO)ESTERS BAYER AG (DE) 1998-09-23 EP claimed
WO-1998022434-A1 GLYOXYLIC ACID AMIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-05-28 WO claimed
EP-0533244-B1 Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists MERCK & CO INC (US) 1997-12-17 EP claimed
EP-0805798-A1 AMINO ACID AMIDE DERIVATIVES AND THEIR USE AS PESTICIDES BAYER AG (DE) 1997-11-12 EP claimed
WO-1997020465-A1 USE OF 1,2,3-THIADIAZOLE CARBOXYLIC ACID (THIO)ESTERS FOR THE CONTROL OF PESTS AND NOVEL 1,2,3-THIADIAZOLE CARBOXYLIC ACID (THIO)ESTERS BAYER AKTIENGESELLSCHAFT (DE) 1997-06-12 WO claimed
US-8420630-B2 Pyrimidine derivatives BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2013-04-16 US disclosed
WO-2003032997-A1 PYRIMIDINE DERIVATIVES, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS, USE AND METHOD FOR MAKING SAME BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-04-24 WO disclosed